The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

MicroStrategy’s Bitcoin strategy has fueled its meteoric rise, but its heavy reliance on cryptocurrency and debt raises ...

TD Cowen has recently reiterated Marathon Petroleum Corp (MPC) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, TD Cowen had reiterated the ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Science Applications International ...

Fintel reports that on January 8, 2025, TD Cowen initiated coverage of Axon Enterprise (NasdaqGS:AXON) with a Buy ...

In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on Halozyme (HALO – Research Report), with a price target of ...

“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...

After a turbulent year, things should calm for payers with the advent of a business-friendly Trump administration — though challenges will persist. Here are experts’ biggest predictions for 2025.

TD Cowen downgraded Kimberly-Clark (KMB) to Hold from Buy with a $145 price target While the firm maintains conviction in the company’s path ...

AI researchers and data scientists. Nvidia announced Project DIGITS — a desktop AI supercomputer with the company’s latest ...